BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27450446)

  • 41. Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder.
    Song J; Bergen SE; Di Florio A; Karlsson R; Charney A; Ruderfer DM; Stahl EA; ; Chambert KD; Moran JL; Gordon-Smith K; Forty L; Green EK; Jones I; Jones L; Scolnick EM; Sklar P; Smoller JW; Lichtenstein P; Hultman C; Craddock N; Landén M; Smoller JW; Perlis RH; Lee PH; Castro VM; Hoffnagle AG; Sklar P; Stahl EA; Purcell SM; Ruderfer DM; Charney AW; Roussos P; Michele Pato CP; Medeiros H; Sobel J; Craddock N; Jones I; Forty L; Florio AD; Green E; Jones L; Gordon-Smith K; Landen M; Hultman C; Jureus A; Bergen S; McCarroll S; Moran J; Smoller JW; Chambert K; Belliveau RA
    Mol Psychiatry; 2016 Sep; 21(9):1290-7. PubMed ID: 26503763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1.
    Chang H; Li L; Peng T; Grigoroiu-Serbanescu M; Bergen SE; Landén M; Hultman CM; Forstner AJ; Strohmaier J; Hecker J; Schulze TG; Müller-Myhsok B; Reif A; Mitchell PB; Martin NG; Cichon S; Nöthen MM; Jamain S; Leboyer M; Bellivier F; Etain B; Kahn JP; Henry C; Rietschel M; ; ; Xiao X; Li M
    Mol Neurobiol; 2017 Sep; 54(7):5166-5176. PubMed ID: 27562178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic genetic analyses of genome-wide association study data reveal an association between the key nucleosome remodeling and deacetylase complex and bipolar disorder development.
    Xiang B; Liu K; Yu M; Liang X; Zhang J; Lei W; Huang C; Chen J; Gu X; Li N; Wu G; Wang Y; He W; Tan J; Zhang T
    Bipolar Disord; 2018 Jun; 20(4):370-380. PubMed ID: 29280245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of pathways for bipolar disorder: a meta-analysis.
    Nurnberger JI; Koller DL; Jung J; Edenberg HJ; Foroud T; Guella I; Vawter MP; Kelsoe JR;
    JAMA Psychiatry; 2014 Jun; 71(6):657-64. PubMed ID: 24718920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder.
    Chuang LC; Kao CF; Shih WL; Kuo PH
    PLoS One; 2013; 8(1):e53092. PubMed ID: 23326387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regional enrichment analyses on genetic profiles for schizophrenia and bipolar disorder.
    Liu J; Chen J; Perrone-Bizzozero NI; Turner JA; Calhoun VD
    Schizophr Res; 2018 Feb; 192():240-246. PubMed ID: 28442247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene set enrichment analysis and expression pattern exploration implicate an involvement of neurodevelopmental processes in bipolar disorder.
    Mühleisen TW; Reinbold CS; Forstner AJ; Abramova LI; Alda M; Babadjanova G; Bauer M; Brennan P; Chuchalin A; Cruceanu C; Czerski PM; Degenhardt F; Fischer SB; Fullerton JM; Gordon SD; Grigoroiu-Serbanescu M; Grof P; Hauser J; Hautzinger M; Herms S; Hoffmann P; Kammerer-Ciernioch J; Khusnutdinova E; Kogevinas M; Krasnov V; Lacour A; Laprise C; Leber M; Lissowska J; Lucae S; Maaser A; Maier W; Martin NG; Mattheisen M; Mayoral F; McKay JD; Medland SE; Mitchell PB; Moebus S; Montgomery GW; Müller-Myhsok B; Oruc L; Pantelejeva G; Pfennig A; Pojskic L; Polonikov A; Reif A; Rivas F; Rouleau GA; Schenk LM; Schofield PR; Schwarz M; Streit F; Strohmaier J; Szeszenia-Dabrowska N; Tiganov AS; Treutlein J; Turecki G; Vedder H; Witt SH; Schulze TG; Rietschel M; Nöthen MM; Cichon S
    J Affect Disord; 2018 Mar; 228():20-25. PubMed ID: 29197740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia.
    Ruderfer DM; Fanous AH; Ripke S; McQuillin A; Amdur RL; ; ; ; Gejman PV; O'Donovan MC; Andreassen OA; Djurovic S; Hultman CM; Kelsoe JR; Jamain S; Landén M; Leboyer M; Nimgaonkar V; Nurnberger J; Smoller JW; Craddock N; Corvin A; Sullivan PF; Holmans P; Sklar P; Kendler KS
    Mol Psychiatry; 2014 Sep; 19(9):1017-1024. PubMed ID: 24280982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of susceptibility loci at 7q31 and 9p13 for bipolar disorder in an isolated population.
    Palo OM; Soronen P; Silander K; Varilo T; Tuononen K; Kieseppä T; Partonen T; Lönnqvist J; Paunio T; Peltonen L
    Am J Med Genet B Neuropsychiatr Genet; 2010 Apr; 153B(3):723-35. PubMed ID: 19851985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.
    Craddock N; Jones L; Jones IR; Kirov G; Green EK; Grozeva D; Moskvina V; Nikolov I; Hamshere ML; Vukcevic D; Caesar S; Gordon-Smith K; Fraser C; Russell E; Norton N; Breen G; St Clair D; Collier DA; Young AH; Ferrier IN; Farmer A; McGuffin P; Holmans PA; ; Donnelly P; Owen MJ; O'Donovan MC
    Mol Psychiatry; 2010 Feb; 15(2):146-53. PubMed ID: 19078961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genes and pathways underlying susceptibility to impaired lung function in the context of environmental tobacco smoke exposure.
    de Jong K; Vonk JM; Imboden M; Lahousse L; Hofman A; Brusselle GG; Probst-Hensch NM; Postma DS; Boezen HM
    Respir Res; 2017 Jul; 18(1):142. PubMed ID: 28738859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide association study on bipolar disorder in the Bulgarian population.
    Yosifova A; Mushiroda T; Kubo M; Takahashi A; Kamatani Y; Kamatani N; Stoianov D; Vazharova R; Karachanak S; Zaharieva I; Dimova I; Hadjidekova S; Milanova V; Madjirova N; Gerdjikov I; Tolev T; Poryazova N; O'Donovan MC; Owen MJ; Kirov G; Toncheva D; Nakamura Y
    Genes Brain Behav; 2011 Oct; 10(7):789-97. PubMed ID: 21771265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region.
    Liu X; ; Kelsoe JR; Greenwood TA
    J Affect Disord; 2016 Jan; 189():141-9. PubMed ID: 26433762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-wide analyses identify novel risk loci for cluster headache in Han Chinese residing in Taiwan.
    Chen SP; Hsu CL; Wang YF; Yang FC; Chen TH; Huang JH; Pan LH; Fuh JL; Chang HC; Lee YL; Chang HC; Lee KH; Chang YC; Fann CS; Wang SJ
    J Headache Pain; 2022 Nov; 23(1):147. PubMed ID: 36404298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring the associations between genetic variants in genes encoding for subunits of calcium channel and subtypes of bipolar disorder.
    Jan WC; Yang SY; Chuang LC; Lu RB; Lu MK; Sun HS; Kuo PH
    J Affect Disord; 2014 Mar; 157():80-6. PubMed ID: 24581832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome-wide association study in bipolar patients stratified by co-morbidity.
    Kerner B; Lambert CG; Muthén BO
    PLoS One; 2011; 6(12):e28477. PubMed ID: 22205951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome‑wide association study and polygenic risk scores predict psoriasis and its shared phenotypes in Taiwan.
    Yang JS; Liu TY; Lu HF; Tsai SC; Liao WL; Chiu YJ; Wang YW; Tsai FJ
    Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38757301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
    O'Dushlaine C; Kenny E; Heron E; Donohoe G; Gill M; Morris D; ; Corvin A
    Mol Psychiatry; 2011 Mar; 16(3):286-92. PubMed ID: 20157312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of age-of-onset groups with GWAS significant schizophrenia and bipolar disorder loci in Romanian bipolar I patients.
    Grigoroiu-Serbanescu M; Diaconu CC; Heilmann-Heimbach S; Neagu AI; Becker T
    Psychiatry Res; 2015 Dec; 230(3):964-7. PubMed ID: 26596365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder.
    Budde M; Friedrichs S; Alliey-Rodriguez N; Ament S; Badner JA; Berrettini WH; Bloss CS; Byerley W; Cichon S; Comes AL; Coryell W; Craig DW; Degenhardt F; Edenberg HJ; Foroud T; Forstner AJ; Frank J; Gershon ES; Goes FS; Greenwood TA; Guo Y; Hipolito M; Hood L; Keating BJ; Koller DL; Lawson WB; Liu C; Mahon PB; McInnis MG; McMahon FJ; Meier SM; Mühleisen TW; Murray SS; Nievergelt CM; Nurnberger JI; Nwulia EA; Potash JB; Quarless D; Rice J; Roach JC; Scheftner WA; Schork NJ; Shekhtman T; Shilling PD; Smith EN; Streit F; Strohmaier J; Szelinger S; Treutlein J; Witt SH; Zandi PP; Zhang P; Zöllner S; Bickeböller H; Falkai PG; Kelsoe JR; Nöthen MM; Rietschel M; Schulze TG; Malzahn D
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):156-170. PubMed ID: 30503783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.